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Case report

Native valve endocarditis complicated by abscess formation caused by
Rothia mucilaginosa
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Rothia mucilaginosa is increasingly recognized as an emerging pathogen associated with endocarditis. It has
mostly been reported a causative agent for prosthetic valve endocarditis. The previously reported cases of
native valve endocarditis caused by this organism only required medical treatment with no surgical in
tervention. We report a case of R. mucilaginosa native valve endocarditis complicated by abscess formation
requiring surgical intervention and review the literature of native valve endocarditis caused by this
organism.
© 2021 The Authors. Published by Elsevier Ltd.
CC_BY_NC_ND_4.0
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Introduction
Rothia spp are gram positive pleomorphic bacteria [1], first re
ported to infect humans in 1975 [2]. Among the different species of
Rothia, three have been described to be pathogenic for humans: R.
aeria, R. dentocariosa, R. mucilaginosa [3]. The latter three species
grow fast under aerobic conditions producing whitish convex co
lonies while they produce filamentous transparent colonies under
anaerobic conditions [3].
Rothia mucilaginosa was formerly known as Staphylococcus sali
varius, and Stomatococcus mucilaginosus [4]. It is a normal inhabitant
of the human oral cavity and respiratory tract [5]. Infections with
this pathogen usually affect immunocompromised hosts such as
patients with cancer, HIV, diabetes mellitus and chronic liver disease
[6,7]. It can also affect immunocompetent hosts with certain risk
factors such as cardiac valve disease/presence of prosthetic valves,
indwelling catheters or IV drug users [4]. It is mostly reported to be
involved in respiratory tract infections [8], soft tissue infections [5],
meningitis [9], endocarditis [3,4], bone and joint infections [1],
central nervous system infections [10] and bacteremia [11].
When infecting cardiac valves, this organism is mostly reported
to cause prosthetic valve endocarditis with rare reports of native
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valve infections. A case series of infective endocarditis caused by
R.mucilaginosa shows that most reported native valve infections re
covered with antibiotics alone while most patient with prosthetic
valve infections required surgical valve replacement [9]. We report a
rare case of native valve Rothia mucilaginosa endocarditis compli
cated by aortic root abscess requiring surgical intervention in
addition to antibiotic therapy.
Case
An 80-year old man with a past medical history of coronary ar
tery disease, mild intermittent asthma and moderate aortic stenosis
presented to the emergency department for evaluation of inter
mittent fevers of three weeks duration. He reported that the fevers
were low grade occurring randomly at no set time of the day. He had
associated lethargy, generalized weakness, decreased oral intake and
intermittent headache. He denied chest pain, palpitations, shortness
of breath, joint pain, or rash. He reported having dental work done 2
months prior to presentation. He denied recent travel or sick con
tacts, intravenous drug use, recent hospitalization, or antibiotic use.
On arrival, the patient was noted to have low grade fever with a
temperature of 100.4°F, tachycardia with a heart rate of 95 beats/
minute and was normotensive. On exam, he was noted to have poor
dentition and a loud harsh systolic murmur consistent with aortic
stenosis. Lung and abdominal exams were unremarkable. No focal
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Table 1
Laboratory workup.

Hemoglobin
White Blood Cells
Platelet count
BUN
Creatinine
Sodium
Potassium
Aspartate aminotransferase
Alanine aminotransferase
Alkaline phosphatase
C-reactive protein
Erythrocyte sedimentation rate
Troponin

Reference range

Admission day

Day 2

Discharge day

11.8–15.7 g/dL
3.80–10.50 K/uL
150–369 K/uL
8–20 mg/dL
0.6–1.1 mg/dL
136–144 mEq/L
3.6–5.1 mEq/L
15–41 IU/L
11–54 IU/L
35–126 IU/L
< =7.48 mg/L
0–20 mm/h
< 0.05 ng/mL

11.6
13.4
247
11
1.0
136
3.9
72
111
70
102.3
77
0.11

11.1
11.6
251
8
0.9
137
3.6
62
108
68
69.4
67
0.06

9.0
13.3
90
11
0.9
138
4.5
27
41
63

Fig. 1. Transesophageal echocardiogram. A: Aortic valve vegetation extending into the LVOT and abutting the anterior mitral leaflet. B: Aortic valve vegetation with aortic root
abscess.

Fig. 2. A: Aortic valve vegetation with aortic root abscess. B: Aortic root repair with insertion of bovine pericardial patch. C: Aortic valve post suture-less bioprosthetic valve
implantation (Corcym Perceval prosthesis).

neurologic signs were found. He had no evidence of heart failure or
stigmata suggestive of underlying endocarditis. Initial laboratory
testing was pertinent for leukocytosis, abnormal liver function tests,
elevated troponin and inflammatory markers [Table 1]. A urine
analysis, hepatitis and viral panel were done and were negative. A
chest X ray was normal. CT abdomen and pelvis with intravenous
contrast revealed a 3.3 × 3.5 cm abdominal aortic aneurysm, ex
tensive coronary artery calcification but no definite source of infec
tion. Two sets of blood cultures were obtained, and results came
back positive for non-staphylococcus gram positive cocci later

identified as Rothia mucilaginosa. The patient was started on
ceftriaxone 2 g daily in addition to IV vancomycin. Repeat blood
cultures cleared on hospital day 2.
Initial transthoracic echocardiogram showed progressive mitral
stenosis, regurgitation with a small mobile echo density attached to
the anterior mitral annulus in addition to severe aortic stenosis. A
transesophageal echocardiogram was done showing an echo dense
highly mobile oscillating structure attached to the left aortic valve
cusp between the noncoronary and left coronary cusp measuring
1 × 1.5 cm consistent with an aortic valve vegetation extending into
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the patient’s skin findings resolving prior to discharge. The patient
was discharged on postoperative day 8 without deficits. He was
continued on ceftriaxone 2 g daily for a total of 42 days.

Discussion
Rothia mucilaginosa is an organism often difficult to identify
secondary to taxonomic confusion and misidentification with other
gram-positive organisms such as staphylococcus, streptococcus or
micrococcus [13]. Rothia infections are classically described as op
portunistic diseases and a systematic review published in 2020
looking at Rothia spp included 61% of infected patients being im
munocompromised with tooth decays reported in 28% of patients
with Rothia infection [3]. In addition to underlying structural valv
ular disease, recent dental work was likely a major risk factor for our
patient to acquire this particular infection.
Table 2 describes seven patients reported in the literature with
native valve infections caused by Rothia mucilaginosa [9,14–19] in
addition to our case. Most reported cases occurred in patients with
underlying valve pathologies [9,14–16,19] or underlying risk factors
such as intravenous drug use [17–19]. Six out of seven patients were
treated with antibiotics alone [9,14–18] and all but one patient had a
favorable outcome [18]. One of the 7 patients required surgical valve
replacement [19]. We report here a rare case of native valve en
docarditis secondary to Rothia mucilaginosa complicated by abscess
formation and requiring two valve replacements.
There are no guidelines to assist in antibiotic selection in the
treatment of invasive Rothia infections [12] and the treatment re
gimen is not clearly determined. The organism is noted to be gen
erally susceptible to penicillin, ampicillin, cefotaxime, imipenem,
rifampin, and vancomycin [4]. In the literature, it has previously
been described to be frequently resistant to clindamycin, ami
noglycosides, trimethoprim sulfamethoxazole [4,20] and occasion
ally to penicillin [19]. In our reported case, the organism was
susceptible to penicillin (MIC < 0.120), Vancomycin (MIC = 1) and
levofloxacin (MIC 0.5). Our isolated strain was intermediately
susceptible to clindamycin (MIC 1) and erythromycin (MIC 2) and
resistant to trimethoprim sulfamethoxazole (MIC > 4).
Rothia mucilaginosa is increasingly recognized as an emerging
pathogen causing infections in both immunocompromised and im
munocompetent hosts. It has mostly been described to cause pros
thetic valve endocarditis [4] requiring both antibiotic therapy and
surgical reconstruction. It, however, can also cause native valve en
docarditis with reports of more aggressive disease emerging as is the
case with our patient, requiring surgical intervention.

Fig. 3. Bullous eruption of patient’s left hand.

the LVOT and abutting the anterior mitral leaflet in addition to an
aortic root abscess with loculations and early dehiscence of the base
of the aortic valve [Fig. 1]. During his stay, patient complained of
recurrent headaches and an MRI brain was done showing at least
two foci of septic emboli in the right occipital lobe and right parietal
lobe with a focus of subarachnoid hemorrhage in the left parietal
sulcus.
On day 10 of hospitalization, patient underwent aortic root
debridement and repair with a pericardial patch, mitral valve repair
with removal of vegetations noted on the anterior leaflet and aortic
valve replacement with a suture-less bovine prosthetic valve [Fig. 2].
The patient had an extensive abscess cavity involving the annulus,
superior aspect of the anterior leaflet of the mitral valve and ex
tending toward the left main coronary ostium. After thorough deb
ridement, obliteration of the abscess cavity and reconstruction was
performed with bovine pericardial patch [12]. Selection of a selfexpanding suture-less prosthesis was intentional to minimize suture
material in the setting of infected space. Pathology of the native
aortic valve showed acute inflammatory infiltrates and necrosis with
tissue cultures negative to date. His course was complicated by atrial
fibrillation requiring cardioversion. On post-operative day 4, he de
veloped a blister eruption on the soles of his feet, bilateral hands,
arms and abdomen [Fig. 3]. This was attributed to possible vanco
mycin induced IgA dermatitis and the drug was discontinued with

Table 2
Eight cases of Rothia mucilaginosa native valve endocarditis reported in the literature and our case.
Reference

Age (years)

Sex

Underlying disease/risk factor

Diagnosis

Treatment

13
14
15
9
16
17
18
Our case

63
34
46
44
46
79
35
60

M
F
M
M
M
M
M
M

Rheumatic heart disease, Moderate MS and MR
IVDU, MV prolapse
MV prolapse
MV prolapse and MR
IVDU
none
IVDU,endocarditis, AI/MI
AS

Native
Native
Native
Native
Native
Native
Native
Native

IV PCN x 5 weeks
IV PCN x 6 weeks
PCN and gentamycin x 4 weeks
IV PCN x 6 weeks
IV vancomycin x 6 weeks
Rifampin+vancomycin (expired)
IV vancomycin x 4 weeks + valve replacement
IV CTX x 4 weeks + valve replacement

3

MV endocarditis
MV endocarditis
MV endocarditis
MV endocarditis
MV endocarditis
AV,MV endocarditis
AV endocarditis
AV,MV endocarditis
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No study was performed on volunteers. This is a descriptive case
report.
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